DAY101 for pLGG Granted Rare Pediatric Disease Status
source: pixabay.com

DAY101 for pLGG Granted Rare Pediatric Disease Status

According to a July 27 news release from biopharmaceutical company Day One Biopharmaceuticals ("Day One"), the company's therapeutic option DAY101 received Rare Pediatric Disease designation within the United States. Altogether,…

Continue Reading DAY101 for pLGG Granted Rare Pediatric Disease Status